Limited sampling strategy for predicting isoniazid exposure in patients with extrapulmonary tuberculosis
出版年份 2019 全文链接
标题
Limited sampling strategy for predicting isoniazid exposure in patients with extrapulmonary tuberculosis
作者
关键词
-
出版物
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-12-13
DOI
10.1111/jcpt.13098
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis
- (2019) Antonia Morita I. Saktiawati et al. CLINICAL PHARMACOKINETICS
- Limited Sampling Strategy for Accurate Prediction of Pharmacokinetics of Saroglitazar: A 3-point Linear Regression Model Development and Successful Prediction of Human Exposure
- (2018) Shuchi N. Joshi et al. CLINICAL THERAPEUTICS
- Limited sampling strategies for determining the area under the plasma concentration–time curve for isoniazid might be a valuable approach for optimizing treatment in adult patients with tuberculosis
- (2017) Piergiorgio Cojutti et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Transdermal Rivastigmine Delivery for Alzheimer Disease
- (2016) Nuggehally R. Srinivas CLINICAL NEUROPHARMACOLOGY
- Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring
- (2016) Roger K. Verbeeck et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients
- (2016) N Ben Fredj et al. PHARMACOGENOMICS JOURNAL
- The challenges of pharmacokinetic variability of first-line anti-TB drugs
- (2016) Bella Devaleenal Daniel et al. Expert Review of Clinical Pharmacology
- Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data
- (2015) Nuggehally R. Srinivas BIOPHARMACEUTICS & DRUG DISPOSITION
- Prediction of area under the curve for a p-glycoprotein, a CYP3A4 and a CYP2C9 substrate using a single time point strategy: assessment using fexofenadine, itraconazole and losartan and metabolites
- (2015) Nuggehally R. Srinivas DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
- (2014) Abdullah Alsultan et al. DRUGS
- Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin
- (2014) C. Magis-Escurra et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Development and Validation of Limited Sampling Strategies for the Estimation of Mycophenolic Acid Area Under the Curve in Adult Kidney and Liver Transplant Recipients Receiving Concomitant Enteric-Coated Mycophenolate Sodium and Tacrolimus
- (2013) Tomasz Pawinski et al. THERAPEUTIC DRUG MONITORING
- Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy
- (2012) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV‐Infected Cohort of Adults with Tuberculosis from Botswana
- (2009) Sekai Chideya et al. CLINICAL INFECTIOUS DISEASES
- Cross-validation and bootstrapping are unreliable in small sample classification
- (2008) A. Isaksson et al. PATTERN RECOGNITION LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search